Last reviewed · How we verify
Ginseol Kg1(high dose)
Ginseol KG1 is a standardized ginseng extract that modulates immune function and metabolic pathways through multiple bioactive ginsenoside components.
Ginseol KG1 is a standardized ginseng extract that modulates immune function and metabolic pathways through multiple bioactive ginsenoside components. Used for Phase 3 indication not publicly specified; likely immune function or metabolic disorder based on ginseng pharmacology.
At a glance
| Generic name | Ginseol Kg1(high dose) |
|---|---|
| Sponsor | Seoul National University Hospital |
| Drug class | Herbal extract / Botanical immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Immunology / General wellness |
| Phase | Phase 3 |
Mechanism of action
Ginseol KG1 contains a defined mixture of ginsenosides and other active compounds derived from Panax ginseng that enhance immune cell activity, reduce inflammatory markers, and improve metabolic parameters. The high-dose formulation is designed to achieve therapeutic concentrations of these bioactive compounds for enhanced clinical efficacy in target conditions.
Approved indications
- Phase 3 indication not publicly specified; likely immune function or metabolic disorder based on ginseng pharmacology
Common side effects
- Gastrointestinal disturbance
- Insomnia or sleep disturbance
- Headache
- Nervousness or anxiety
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |